Development of screening tools to identify psoriatic arthritis

Current Rheumatology Reports

Volumn 12, Issue 4, 2010, Pages 295-299

  Dominguez, Patrick ^a   Gladman, Dafna D ^b   Helliwell, Philip ^c   Mease, Philip J ^d   Husni, M Elaine ^e   Qureshi, Abrar A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Psoriasis; Psoriatic arthritis; Screening

Indexed keywords

ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; DELAYED DIAGNOSIS; DISEASE ACTIVITY; DISEASE SEVERITY; HUMAN; PSORIASIS; PSORIASIS EPIDEMIOLOGY SCREENING TOOL; PSORIATIC ARTHRITIS; PSORIATIC ARTHRITIS SCREENING AND EVALUATION TOOL; QUESTIONNAIRE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TORONTO PSORIATIC ARTHRITIS SCREEN; VALIDATION PROCESS; ARTHRITIS, PSORIATIC; MASS SCREENING; PREVALENCE; PROCEDURES;

ARTHRITIS, PSORIATIC; HUMANS; MASS SCREENING; PREVALENCE; QUESTIONNAIRES;

EID: 77955984528     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-010-0113-2     Document Type: Article

References (16)

1. H Zachariae 2003 Prevalence of joint disease in patients with psoriasis: implications for therapy Am J Clin Dermatol 4 441 447 10.2165/00128071- 200304070-00001 12814334
2. P Mease BS Goffe 2005 Diagnosis and treatment of psoriatic arthritis J Am Acad Dermatol 52 1 19 10.1016/j.jaad.2004.06.013 15627075
3. J Brockbank D Gladman 2002 Diagnosis and management of psoriatic arthritis Drugs 62 2447 2457 10.2165/00003495-200262170-00004 1:CAS:528:DC%2BD38Xps1yjtb8%3D 12421102
4. DD Gladman J Brockbank 2000 Psoriatic arthritis Expert Opin Investig Drugs 9 1511 1522 10.1517/13543784.9.7.1511 1:STN:280:DC%2BD3M%2Fot1WktA%3D%3D 11060756
5. W Taylor D Gladman P Helliwell, et al. 2006 Classification criteria for psoriatic arthritis: development of new criteria from a large international study Arthritis Rheum 54 2665 2673 10.1002/art.21972 16871531
6. PM Peloso P Hull B Reeder 1997 The psoriasis and arthritis questionnaire (PAQ) in detection of arthritis among patients with psoriasis Arthritis Rheum 40 S64
7. GM Alenius B Stenberg H Stenlund, et al. 2002 Inflammatory joint manifestations are prevalent in psoriasis: prevalence study of joint and axial involvement in psoriatic patients, and evaluation of a psoriatic and arthritic questionnaire J Rheumatol 29 2577 2582 12465155
8. Qureshi AA, Dominguez P, Duffin KC, et al.: Psoriatic arthritis screening tools. J Rheumatol 2008, 35:1423-1425. This is an update on the development of screening tools for PsA that was presented during the 2009 GRAPPA annual meeting. It includes feedback from GRAPPA members on what should constitute an effective screening tool.
9. Husni ME, Meyer KH, Cohen DS, et al.: The PASE questionnaire: pilot-testing a psoriatic arthritis screening and evaluation tool. J Am Acad Dermatol 2007, 57:581-587. This was the first validation pilot study of the PASE questionnaire, jointly developed by rheumatologists and dermatologists, which shows the PASE to be an effective screening tool to identify inflammatory arthritis and to distinguish it from noninflammatory arthritis.
10. •• Dominguez PL, Husni ME, Holt EW, et al.: Validity, reliability, and sensitivity-to-change properties of the psoriatic arthritis screening and evaluation questionnaire. Arch Dermatol Res 2009, 301:573-579. This was the second validation study of the PASE questionnaire in a larger patient population that showed the PASE to be sensitive to change and to have test-retest reliability.
11. DD Gladman CT Schentag B Tom, et al. 2007 Development and validation of a screening questionnaire for psoriatic arthritis Arthritis Rheum 56 Suppl 9 S798
12. •• Gladman DD, Schentag CT, Tom BD, et al.: Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS). Ann Rheum Dis 2009, 68:497-501. This article describes the initial development of the ToPAS questionnaire, a psoriasis and PsA screening tool, and its validation in various clinical settings.
13. •• Ibrahim GH, Buch MH, Lawson C, et al.: Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire. Clin Exp Rheumatol 2009, 27:469-474. This article describes the development and validation of the PEST questionnaire, a PsA screening tool, in a community-based setting.
14. JM Gelfand DD Gladman PJ Mease, et al. 2005 Epidemiology of psoriatic arthritis in the population of the United States J Am Acad Dermatol 53 573 10.1016/j.jaad.2005.03.046 16198775
15. SR Feldman AB Fleischer Jr JZ Cooper 2000 New topical treatments change the pattern of treatment of psoriasis: dermatologists remain the primary providers of this care Int J Dermatol 39 41 44 10.1046/j.1365-4362.2000.00878.x 1:STN:280:DC%2BD3c7hslylsg%3D%3D 10651966
16. GM Alenius B Stenberg H Stenlund, et al. 2002 Inflammatory joint manifestations are prevalent in psoriasis: prevalence study of joint and axial involvement in psoriatic patients, and evaluation of a psoriatic and arthritic questionnaire J Rheumatol 29 2577 2582 12465155